Noninvasive Prenatal DNA Testing: The Vanguard of Genomic Medicine

Overview

Journal Annu Rev Med

Publisher Annual Reviews

Specialty General Medicine

Date 2016 Oct 13

PMID 27732785

Citations 20

Authors

Lisa Hui

Diana W Bianchi

Affiliations

Soon will be listed here.

Abstract

Noninvasive prenatal DNA testing is the vanguard of genomic medicine. In only four years, this screening test has revolutionized prenatal care globally and opened up new prospects for personalized medicine for the fetus. There are widespread implications for increasing the scope of human genetic variation that can be detected before birth, and for discovering more about maternofetal and placental biology. These include an urgent need to develop pretest education for all pregnant women and consistent post-test management recommendations for those with discordant test results. The reduction in invasive testing has had downstream effects on specialist training and caused many countries to re-examine their national approaches to prenatal screening. Finally, the accumulating datasets of genomic information on pregnant women and their fetuses raise ethical issues regarding consent for future data mining and intellectual property.

Citing Articles

Noninvasive prenatal screening in a pregnant woman with a history of stem cell transplant from a male donor: A case report and literature review.

Liang D, Lin Y, Luo C, Li H, Hu P, Xu Z Mol Genet Genomic Med. 2024; 12(6):e2479.

PMID: 38860502 PMC: 11165337. DOI: 10.1002/mgg3.2479.

Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France.

Bowman-Smart H, Perrot A, Horn R BMC Med Ethics. 2024; 25(1):34.

PMID: 38515078 PMC: 10956335. DOI: 10.1186/s12910-024-01032-0.

Non-invasive prenatal testing (NIPT): is routinization problematic?.

Rehmann-Sutter C, Timmermans D, Raz A BMC Med Ethics. 2023; 24(1):87.

PMID: 37884894 PMC: 10604734. DOI: 10.1186/s12910-023-00970-5.

Association between chromosome abnormities and prenatal diagnosis indicators screening in the second trimester of pregnancy.

Pan C, Li Z, Cheng G, Luo X, Nie F, Gao J Medicine (Baltimore). 2023; 102(35):e34762.

PMID: 37657051 PMC: 10476756. DOI: 10.1097/MD.0000000000034762.

Non-invasive prenatal testing in Germany: a unique ethical and policy landscape.

Bowman-Smart H, Wiesemann C, Horn R Eur J Hum Genet. 2022; 31(5):562-567.

PMID: 36509835 PMC: 10172332. DOI: 10.1038/s41431-022-01256-x.

References

. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007; 109(1):217-27. DOI: 10.1097/00006250-200701000-00054. View

Tabor A, Vestergaard C, Lidegaard O . Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol. 2009; 34(1):19-24. DOI: 10.1002/uog.6377. View

Snyder H, Curnow K, Bhatt S, Bianchi D . Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling. Prenat Diagn. 2016; 36(3):203-9. PMC: 5067681. DOI: 10.1002/pd.4778. View

Weeke P, Roden D . Applied pharmacogenomics in cardiovascular medicine. Annu Rev Med. 2013; 65:81-94. PMC: 4081861. DOI: 10.1146/annurev-med-101712-122545. View

Lo K, Karampetsou E, Boustred C, McKay F, Mason S, Hill M . Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities. Am J Hum Genet. 2015; 98(1):34-44. PMC: 4716686. DOI: 10.1016/j.ajhg.2015.11.016. View

Dharajiya N, Namba A, Horiuchi I, Miyai S, Farkas D, Almasri E . Uterine leiomyoma confounding a noninvasive prenatal test result. Prenat Diagn. 2015; 35(10):990-3. DOI: 10.1002/pd.4629. View

. Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016; 127(5):979-981. DOI: 10.1097/AOG.0000000000001439. View

Sago H, Sekizawa A . Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience. Prenat Diagn. 2014; 35(4):331-6. DOI: 10.1002/pd.4539. View

Hui L, The S, McCarthy E, Walker S . Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era. Aust N Z J Obstet Gynaecol. 2015; 55(6):541-6. DOI: 10.1111/ajo.12396. View

10.

Lui Y, Chik K, Chiu R, Ho C, Lam C, Lo Y . Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002; 48(3):421-7. View

11.

Minear M, Lewis C, Pradhan S, Chandrasekharan S . Global perspectives on clinical adoption of NIPT. Prenat Diagn. 2015; 35(10):959-67. PMC: 5065727. DOI: 10.1002/pd.4637. View

12.

Dar P, Curnow K, Gross S, Hall M, Stosic M, Demko Z . Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014; 211(5):527.e1-527.e17. DOI: 10.1016/j.ajog.2014.08.006. View

13.

Williams 3rd J, Rad S, Beauchamp S, Ratousi D, Subramaniam V, Farivar S . Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing. Am J Obstet Gynecol. 2015; 213(1):102.e1-102.e6. DOI: 10.1016/j.ajog.2015.04.005. View

14.

Bianchi D, Chudova D, Sehnert A, Bhatt S, Murray K, Prosen T . Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. JAMA. 2015; 314(2):162-9. DOI: 10.1001/jama.2015.7120. View

15.

Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman O, Madan J . Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open. 2016; 6(1):e010002. PMC: 4735304. DOI: 10.1136/bmjopen-2015-010002. View

16.

Gil M, Quezada M, Revello R, Akolekar R, Nicolaides K . Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015; 45(3):249-66. DOI: 10.1002/uog.14791. View

17.

Scior K, Addai-Davis J, Kenyon M, Sheridan J . Stigma, public awareness about intellectual disability and attitudes to inclusion among different ethnic groups. J Intellect Disabil Res. 2012; 57(11):1014-26. DOI: 10.1111/j.1365-2788.2012.01597.x. View

18.

Taglauer E, Wilkins-Haug L, Bianchi D . Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014; 35 Suppl:S64-8. PMC: 4886648. DOI: 10.1016/j.placenta.2013.11.014. View

19.

Dondorp W, de Wert G, Bombard Y, Bianchi D, Bergmann C, Borry P . Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015; 23(11):1592. PMC: 4613480. DOI: 10.1038/ejhg.2015.109. View

20.

Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y . Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2013; 60(1):251-9. DOI: 10.1373/clinchem.2013.215145. View